Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
19.03. | IntelliPharmaCeutics International Inc (2): IntelliPharmaCeutics lists on NEX | 7 | Stockwatch | ||
13.03. | IntelliPharmaCeutics International Inc (2): IntelliPharmaCeutics stuck on NEX over disclosures | 2 | Stockwatch | ||
13.03. | Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan | 314 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / March 13, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the... ► Artikel lesen | |
07.03. | Intellipharmaceutics International Inc. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
06.03. | IntelliPharmaCeutics International Inc (2): IntelliPharmaCeutics receives cease trade order | 2 | Stockwatch | ||
06.03. | Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Cease Trade Order | 496 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / March 6, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research... ► Artikel lesen | |
06.03. | IntelliPharmaCeutics International Inc (2): IntelliPharmaCeutics International halted at the open | 2 | Stockwatch | ||
27.02. | Intellipharmaceutics International Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
27.02. | Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form | 367 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / February 26, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the... ► Artikel lesen | |
08.02. | IntelliPharmaCeutics International Inc (2): IntelliPharmaCeutics grants options to buy 1.91M shares | - | Stockwatch | ||
08.02. | Intellipharmaceutics International Inc. Announces Stock Option Grant | 356 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / February 8, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the... ► Artikel lesen | |
03.01. | Intellipharmaceutics receives conditional approval to list on the TSX Venture Exchange | 3 | Seeking Alpha | ||
02.01. | IntelliPharmaCeutics International Inc (2): IntelliPharmaCeutics receives cond. OK to list on TSX-V | 1 | Stockwatch | ||
02.01. | Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange | 519 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / January 2, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 454 |
NVIDIA | 263 |
DEUTSCHE BANK | 258 |
BAYER | 221 |
TESLA | 211 |
BYD | 194 |
RHEINMETALL | 193 |
NEL | 184 |
TUI | 166 |
SUPER MICRO COMPUTER | 156 |
BASF | 121 |
MERCEDES-BENZ | 114 |
AMAZON | 107 |
RWE | 106 |
VARTA | 102 |
MICROSOFT | 100 |
THYSSENKRUPP | 100 |
PLUG POWER | 99 |
AIXTRON SE | 95 |
COMMERZBANK | 95 |
VOLKSWAGEN | 95 |
XIAOMI | 95 |
DEUTSCHE LUFTHANSA | 91 |
ALPHABET | 85 |
DELIVERY HERO | 82 |